Cartesian Therapeutics In... (RNAC)

NASDAQ: RNAC · Real-Time Price · USD

12.94

0.67 (5.46%)

At close: May 02, 2025, 2:31 PM

Cartesian Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-77.42M	-219.71M	35.38M	-25.69M	-68.88M	-55.35M	-65.34M	-65.32M	-36.21M
Depreciation & Amortization	1.15M	1.55M	1.29M	1.25M	734K	2.03M	975K	750K	802K
Stock-Based Compensation	6.58M	22.52M	11.19M	7.72M	5.42M	n/a	n/a	n/a	n/a
Other Working Capital	-10.84M	1.23M	-64.71M	-45.5M	94.46M	1.12M	-265K	9.3M	9.91M
Other Non-Cash Items	51.52M	158.5M	2.29M	2.13M	1.75M	16.02M	8.45M	9.09M	830K
Deferred Income Tax	287K	-19M	-21.4M	2.4M	10.85M	n/a	n/a	n/a	n/a
Change in Working Capital	-5.79M	4.97M	-60.38M	-48.19M	85M	-4.48M	-781K	7.12M	13.2M
Operating Cash Flow	-23.67M	-51.16M	-31.63M	-60.38M	34.88M	-51.44M	-59.16M	-52.04M	-19.68M
Capital Expenditures	-9.09M	-206K	-1.2M	-1.08M	-815K	-47K	-884K	-733K	-586K
Cash Acquisitions	n/a	6.56M	n/a	n/a	74K	122K	99K	4K	2K
Purchase of Investments	n/a	n/a	-33.5M	-32.45M	n/a	-18.19M	-15.6M	-61.53M	-28.42M
Sales Maturities Of Investments	n/a	28.25M	19.7M	16.4M	n/a	18.34M	41.66M	60.16M	n/a
Other Investing Acitivies	351K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.9M
Investing Cash Flow	-8.74M	34.61M	-15M	-17.14M	-741K	229K	25.27M	-2.1M	-22.1M
Debt Repayment	n/a	-27.46M	n/a	n/a	5.42M	-2.8M	n/a	8.02M	n/a
Common Stock Repurchased	n/a	-6.17M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.99M	231K	235K	939K	-3.37M	70.18M	697K	886K	-3.95M
Financial Cash Flow	168.43M	-13.14M	39.22M	52.9M	14.43M	105.04M	697K	66.02M	67.66M
Net Cash Flow	135.99M	-29.75M	-7.4M	-24.63M	48.51M	52.77M	-33.3M	11.96M	25.88M
Free Cash Flow	-32.77M	-51.37M	-32.83M	-61.47M	34.07M	-51.48M	-60.05M	-52.77M	-20.27M